News Briefs Haya Therapeutics lands $65m Series A Sofinnova Partners and Earlybird Venture Capital led the round. Iris Dorbian - 8 May 2025 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
